Lawrence Steinman's Net Worth
$11.7 Million
Who is Lawrence Steinman?
Lawrence Steinman has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include NEUROCRINE BIOSCIENCES INC, Pasithea Therapeutics Corp., 180 Life Sciences Corp., Atreca, Inc., and BioAtla, Inc..
SEC CIK
Lawrence Steinman's CIK is 0001132679
Past Insider Trading and Trends
2022 was Lawrence Steinman's most active year for acquiring shares with 11 total transactions. Lawrence Steinman's most active month to acquire stocks was the month of May. 2005 was Lawrence Steinman's most active year for disposing of shares, totalling 4 transactions. Lawrence Steinman's most active month to dispose stocks was the month of February. 2004 saw Lawrence Steinman paying a total of $690,120.00 for 12,000 shares, this is the most they've acquired in one year. In 2005 Lawrence Steinman cashed out on 4,000 shares for a total of $164,406.02, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.51% | -4.00K |
$41.10 | -$164,406.02 | 15.5K |
Mar 2
| |||
Form 4
| -9.30% | -2.00K |
$50.25 | -$100,509.00 | 19.5K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pasithea Therapeutics Corp. (KTTA) Snapshot price: $7.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +2.31% | 30K |
$0.43 | $12,930.00 | 1.33M |
Jun 2
| |||
Form 4
| +0.39% | 5K |
$0.98 | $4,900.00 | 1.29M |
Nov 28
| |||
Form 4
| +0.39% | 5K |
$0.99 | $4,950.00 | 1.28M |
Nov 22
| |||
Form 4
| +0.39% | 5K |
$1.10 | $5,500.00 | 1.28M |
Oct 26
| |||
Form 4
| +0.79% | 10K |
$1.13 | $11,310.00 | 1.27M |
Oct 17
| |||
Form 4
| +0.79% | 10K |
$1.01 | $10,100.00 | 1.27M |
Jun 28 - Jun 29
| |||
Form 4
| +0.40% | 5K |
$1.00 | $5,000.00 | 1.26M |
Jun 27
| |||
Form 4
| +0.40% | 5K |
$1.00 | $5,000.00 | 1.26M |
Jun 23
| |||
Form 4
| +108.70% | 652.17K |
—
|
—
| 1.25M |
Aug 2 - Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
180 Life Sciences Corp. (ATNF) Snapshot price: $0.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
| +59.74% | 18K |
$1.23 | $22,068.00 | 48.13K |
Jun 1
| |||
Form 4
| +0.84% | 5K |
$4.27 | $21,350.00 | 602.57K |
Dec 8 - Dec 9
| |||
Form 4
| +0.88% | 5.22K |
$6.00 | $31,296.00 | 597.57K |
Sep 30
| |||
Form 4
| +3.96% | 22.59K |
$6.14 | $138,671.90 | 592.36K |
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Atreca, Inc. (BCEL) Snapshot price: $0.258
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.36% | 8.4K |
—
|
—
| 258.4K |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioAtla, Inc. (BCAB) Snapshot price: $2.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +108.35% | 20K |
$2.05 | $41,048.00 | 38.46K |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -2.38% | -450.00 |
$30.00 | -$13,500.00 | 18.46K |
Scheduled
|
Nov 2
| ||
Form 4
| -2.32% | -450.00 |
$36.82 | -$16,569.00 | 18.91K |
Scheduled
|
Sep 15
| ||
Form 4
| -2.27% | -450.00 |
$40.60 | -$18,270.00 | 19.36K |
Scheduled
|
Aug 16
| ||
Form 4
| -2.22% | -450.00 |
$38.29 | -$17,230.50 | 19.81K |
Scheduled
|
Jul 15
| ||
Form 4
| +36.23% | 5.39K |
—
|
—
| 20.26K |
Jun 14 - Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||